Suzuki Toshio, Tada Yuji, Kawata Naoko, Ikari Jun, Kasahara Yasunori, Sakurai Yoriko, Iesato Ken, Nishimura Rintaro, West James, Tatsumi Koichiro
Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Int J Chron Obstruct Pulmon Dis. 2015 Jun 19;10:1199-205. doi: 10.2147/COPD.S82910. eCollection 2015.
The COPD assessment test (CAT) score is a key component of the multifactorial assessment of COPD in the Global initiative for chronic Obstructive Lung Disease (GOLD) guidelines of 2014. Nevertheless, little is known regarding the differences among COPD categories in terms of clinical parameters such as pulmonary function or radiological findings. Thus, our aims in this study were to evaluate the associations between CAT scores and pulmonary clinical parameters, and to investigate factors that could discriminate between a "less symptomatic group" (categories A and C) and a "more symptomatic group" (categories B and D) among stable COPD patients.
We enrolled 200 outpatients at Chiba University Hospital. Study subjects were assessed by CAT, pulmonary function testing, and multidetector computed tomography (MDCT). We assessed possible correlations between these indices.
CAT scores were negatively correlated with percentage of the forced expiratory volume in 1 second predicted value (FEV1 %predicted) and percentage of the diffusing capacity for carbon monoxide per liter of lung volume predicted value (DLCO/VA [%predicted]) results and positively correlated with low attenuation volume percentage (LAV%) and residual volume to total lung capacity ratios (RV/TLC). In the "more symptomatic group" (category B or D), the mean DLCO/VA (%predicted) was significantly lower and the mean LAV% and RV/TLC was significantly higher than those in the "less symptomatic group" (category A or C), respectively. Interestingly, those in category B had higher mean LAV% compared to those in category C.
CAT scores were significantly correlated with pulmonary function parameters and emphysematous changes on MDCT. The new GOLD classification system would be a step toward a phenotypic approach, especially taking into account the degree of emphysema and hyperinflation.
慢性阻塞性肺疾病评估测试(CAT)评分是2014年慢性阻塞性肺疾病全球倡议(GOLD)指南中慢性阻塞性肺疾病多因素评估的关键组成部分。然而,关于慢性阻塞性肺疾病不同类别在肺功能或放射学表现等临床参数方面的差异,人们了解甚少。因此,本研究的目的是评估CAT评分与肺部临床参数之间的关联,并调查能够区分稳定期慢性阻塞性肺疾病患者中“症状较轻组”(A类和C类)和“症状较重组”(B类和D类)的因素。
我们纳入了千叶大学医院的200名门诊患者。研究对象接受了CAT评估、肺功能测试和多排螺旋计算机断层扫描(MDCT)。我们评估了这些指标之间可能存在的相关性。
CAT评分与1秒用力呼气容积预测值百分比(FEV1%预测值)和每升肺容积一氧化碳弥散量预测值百分比(DLCO/VA[%预测值])结果呈负相关,与低衰减容积百分比(LAV%)和残气量与肺总量比值(RV/TLC)呈正相关。在“症状较重组”(B类或D类)中,平均DLCO/VA(%预测值)显著低于“症状较轻组”(A类或C类),而平均LAV%和RV/TLC则显著高于“症状较轻组”。有趣的是,与C类相比,B类患者的平均LAV%更高。
CAT评分与肺功能参数以及MDCT上的肺气肿改变显著相关。新的GOLD分类系统将朝着表型方法迈出一步,特别是考虑到肺气肿和肺过度充气的程度。